感染症診断検査の世界市場レポート 2025年

感染症診断検査市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.1％で625億8,000万米ドルに成長します。予測期間の成長は、新型インフルエンザやCOVID-19のような新種の病原体の継続的な出現、個別化医療や標的治療へのシフト、迅速かつオンサイトの検査ソリューションに対する需要の増加、疫学的サーベイランスや早期発見システムの重視の高まり、新規診断技術やバイオマーカーの開発に焦点を当てた研究開発活動の活発化などに起因すると考えられます。予測期間における主な動向としては、診断機器の小型化・携帯化、複数の病原体を同時に検出できるマルチプレックスアッセイの採用、モバイルアプリや遠隔医療プラットフォームなどのデジタルヘルスソリューションの統合、感染症診断における次世代シーケンシング（NGS）技術の採用、感染因子を迅速かつ高感度に検出するバイオセンサー技術の進歩、診断プラットフォームへのAI・機械学習アルゴリズムの統合などが挙げられます。

感染症診断検査市場は、呼吸器感染症の増加により成長が見込まれます。呼吸器感染症は、呼吸器系のさまざまな部分に影響を及ぼし、密接な接触、不衛生、混雑した生活環境、季節変動などによるウイルスや細菌のトランスミッションによって引き起こされます。感染症の診断検査は、呼吸器感染症の正確な特定と治療のために極めて重要であり、患者サンプル中のウイルスや細菌などの病原体の正確な検出を可能にします。例えば、急性上気道感染症による入院は、2022年の2,114症例から2023年には2,797症例へと32%増加したと、カナダ保健情報研究所が報告しています。

感染症診断検査市場の主要企業は、競争力を維持するため、特に分子診断プラットフォームの技術革新に注力しています。これらのプラットフォームは、診断目的で生物学的サンプルから核酸を検出・分析するために設計された高度なシステムです。ベクトン・ディッキンソンアンドカンパニーは最近、最大1,700検体のハイスループット処理が可能で、24時間以内に結果が得られる自動化感染症分子診断プラットフォーム、BD CORシステムを発売しました。このプラットフォームは、分子検査室のワークフローを合理化し、HPVやSTIなどの疾患の効率性と診断精度を向上させる。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界感染症診断検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の感染症診断検査市場：成長率分析
• 世界の感染症診断検査市場の実績：規模と成長, 2019-2024
• 世界の感染症診断検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界感染症診断検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の感染症診断検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 分子診断検査
• ポイントオブケアテスト（POCT）感染症診断検査
• 世界の感染症診断検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 呼吸器
• ヒト免疫不全ウイルス（HIV）
• ヘルスケア関連感染症（HAI）
• 性的な健康
• 熱帯病
• 肝臓
• 世界の感染症診断検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断検査室
• 病院と診療所
• 学術調査機関
• その他のエンドユーザー
• 世界の感染症診断検査市場分子診断検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリメラーゼ連鎖反応（PCR）検査
• 核酸増幅検査（NAAT）
• 次世代シーケンシング（NGS）
• マイクロアレイベースの検査
• 世界の感染症診断検査市場、ポイントオブケア検査（POCT）感染症診断検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ラテラルフローアッセイ
• 迅速抗原検査
• 免疫測定
• ポータブルPCR

第7章 地域別・国別分析

• 世界の感染症診断検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の感染症診断検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 感染症診断検査市場：競合情勢
• 感染症診断検査市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson And Company
• Quest Diagnostics Incorporated
• Grifols S.A.
• Hologic Inc.
• PerkinElmer Inc.
• bioMerieux SA
• Quidel Corporation
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• DiaSorin SpA（Luminex）
• Myriad Genetics Inc.
• Seegene Inc.
• Ortho Clinical Diagnostics Inc.
• OraSure Technologies Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 感染症診断検査市場2029：新たな機会を提供する国
• 感染症診断検査市場2029：新たな機会を提供するセグメント
• 感染症診断検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Infectious disease diagnostics testing involves identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient's body. These tests are critical for diagnosing infectious diseases and making appropriate treatment decisions. They play a crucial role in controlling the spread of infectious diseases, guiding treatment choices, and monitoring outbreaks.

The main types of infectious disease diagnostics testing are molecular diagnostic tests and point-of-care tests (POCT) for infectious diseases. Molecular diagnostic testing refers to laboratory techniques that detect and analyze genetic material (DNA or RNA) to diagnose diseases, identify pathogens, and predict treatment responses. These tests find applications in areas such as respiratory infections, human immunodeficiency virus (HIV), healthcare-associated infections (HAIS), sexual health, tropical diseases, and liver diseases. They are utilized by various end-users including diagnostic laboratories, hospitals and clinics, academic research institutes, and other healthcare providers.

The infectious disease diagnostics testing market research report is one of a series of new reports from The Business Research Company that provides infectious disease diagnostics testing market statistics, including infectious disease diagnostics testing industry global market size, regional shares, competitors with an infectious disease diagnostics testing market share, detailed infectious disease diagnostics testing market segments, market trends, and opportunities, and any further data you may need to thrive in the infectious disease diagnostics testing industry. This infectious disease diagnostics testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The infectious disease diagnostics testing market size has grown rapidly in recent years. It will grow from $38.52 billion in 2024 to $42.56 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising disease outbreaks such as SARS, Ebola, and Zika, growing awareness among healthcare professionals and the general public about the importance of early detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, control, and prevention, increasing global travel and trade have facilitated the spread of infectious diseases, and increased healthcare spending, particularly in emerging economies.

The infectious disease diagnostics testing market size is expected to see rapid growth in the next few years. It will grow to $62.58 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the continuous emergence of novel pathogens, such as new strains of influenza or COVID-19es, the shift towards personalized medicine and targeted therapies, increasing demand for rapid and on-site testing solutions, Growing emphasis on epidemiological surveillance and early detection systems, and increased research and developments activities focused on developing novel diagnostic technologies and biomarkers. Major trends in the forecast period include miniaturization and portability of diagnostic devices, adoption of multiplex assays capable of detecting multiple pathogens simultaneously, integration of digital health solutions, such as mobile apps and telemedicine platforms, adoption of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies for rapid and sensitive detection of infectious agents, and integration of AI and machine learning algorithms into diagnostic platforms.

The infectious disease diagnostic testing market is anticipated to experience growth due to an increase in respiratory infections. Respiratory infections affect various parts of the respiratory system and are caused by viral and bacterial transmission through close contact, poor hygiene, crowded living conditions, and seasonal variations. Diagnostic testing for infectious diseases is crucial for accurate identification and treatment of respiratory infections, enabling the precise detection of pathogens such as viruses and bacteria in patient samples. For example, hospitalizations for acute upper respiratory infections saw a 32% increase from 2,114 cases in 2022 to 2,797 cases in 2023, as reported by the Canadian Institute for Health Information.

Leading companies in the infectious disease diagnostic testing market are focusing on innovation, particularly in molecular diagnostics platforms, to remain competitive. These platforms are sophisticated systems designed to detect and analyze nucleic acids from biological samples for diagnostic purposes. Becton Dickinson and Company recently launched the BD COR System, an automated infectious disease molecular diagnostics platform capable of high-throughput processing of up to 1,700 specimens with results delivered within 24 hours. This platform streamlines the molecular laboratory workflow, enhancing efficiency and diagnostic accuracy for diseases such as HPV and STIs.

In August 2022, SSI Diagnostica Group (SSID) acquired TechLab Inc., a US-based developer of infectious disease diagnostic products. This acquisition strengthens SSI Diagnostica Group's position in the infectious disease diagnostics market, aligning with their objectives of portfolio expansion, technological enhancement, and market share growth.

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Myriad Genetics Inc., Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC, Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

North America was the largest region in the infectious disease diagnostics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease diagnostics testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease diagnostics testing market consists of revenues earned by entities by providing services such as laboratory testing, point-of-care testing, molecular diagnostics, immunoassays, and rapid diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease diagnostics testing market also includes sales of diagnostic kits, reagents, instruments, and software used for detecting and identifying infectious agents in patients. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease Diagnostics Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infectious disease diagnostics testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease diagnostics testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The infectious disease diagnostics testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Molecular Diagnostic Test; Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
• 2) By Application: Respiratory; Human Immunodeficiency Virus (HIV); Healthcare-Associated Infections (HAIs); Sexual Health; Tropical Diseases; Liver
• 3) By End-User: Diagnostic Laboratories; Hospitals And Clinics; Academic Research Institutes; Other End-Users
• Subsegments:
• 1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests; Nucleic Acid Amplification Tests (NAATs); Next-Generation Sequencing (NGS); Microarray-Based Tests
• 2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays; Rapid Antigen Tests; Immunoassays; Portable PCR
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Infectious Disease Diagnostics Testing Market Characteristics

3. Infectious Disease Diagnostics Testing Market Trends And Strategies

4. Infectious Disease Diagnostics Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Infectious Disease Diagnostics Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Infectious Disease Diagnostics Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Infectious Disease Diagnostics Testing Market Growth Rate Analysis
• 5.4. Global Infectious Disease Diagnostics Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Infectious Disease Diagnostics Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Infectious Disease Diagnostics Testing Total Addressable Market (TAM)

6. Infectious Disease Diagnostics Testing Market Segmentation

• 6.1. Global Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Diagnostic Test
• Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
• 6.2. Global Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Respiratory
• Human Immunodeficiency Virus (HIV)
• Healthcare Associated Infections (HAIs)
• Sexual Health
• Tropical Diseases
• Liver
• 6.3. Global Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Laboratories
• Hospitals And Clinics
• Academic Research Institutes
• Other End-Users
• 6.4. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Molecular Diagnostic Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR) Tests
• Nucleic Acid Amplification Tests (NAATs)
• Next-Generation Sequencing (NGS)
• Microarray-Based Tests
• 6.5. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Point Of Care Tests (POCT) Infectious Disease Diagnostics Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lateral Flow Assays
• Rapid Antigen Tests
• Immunoassays
• Portable PCR

7. Infectious Disease Diagnostics Testing Market Regional And Country Analysis

• 7.1. Global Infectious Disease Diagnostics Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Infectious Disease Diagnostics Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infectious Disease Diagnostics Testing Market

• 8.1. Asia-Pacific Infectious Disease Diagnostics Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infectious Disease Diagnostics Testing Market

• 9.1. China Infectious Disease Diagnostics Testing Market Overview
• 9.2. China Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infectious Disease Diagnostics Testing Market

• 10.1. India Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infectious Disease Diagnostics Testing Market

• 11.1. Japan Infectious Disease Diagnostics Testing Market Overview
• 11.2. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infectious Disease Diagnostics Testing Market

• 12.1. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infectious Disease Diagnostics Testing Market

• 13.1. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infectious Disease Diagnostics Testing Market

• 14.1. South Korea Infectious Disease Diagnostics Testing Market Overview
• 14.2. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infectious Disease Diagnostics Testing Market

• 15.1. Western Europe Infectious Disease Diagnostics Testing Market Overview
• 15.2. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infectious Disease Diagnostics Testing Market

• 16.1. UK Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infectious Disease Diagnostics Testing Market

• 17.1. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infectious Disease Diagnostics Testing Market

• 18.1. France Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infectious Disease Diagnostics Testing Market

• 19.1. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infectious Disease Diagnostics Testing Market

• 20.1. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infectious Disease Diagnostics Testing Market

• 21.1. Eastern Europe Infectious Disease Diagnostics Testing Market Overview
• 21.2. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infectious Disease Diagnostics Testing Market

• 22.1. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infectious Disease Diagnostics Testing Market

• 23.1. North America Infectious Disease Diagnostics Testing Market Overview
• 23.2. North America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infectious Disease Diagnostics Testing Market

• 24.1. USA Infectious Disease Diagnostics Testing Market Overview
• 24.2. USA Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infectious Disease Diagnostics Testing Market

• 25.1. Canada Infectious Disease Diagnostics Testing Market Overview
• 25.2. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infectious Disease Diagnostics Testing Market

• 26.1. South America Infectious Disease Diagnostics Testing Market Overview
• 26.2. South America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infectious Disease Diagnostics Testing Market

• 27.1. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infectious Disease Diagnostics Testing Market

• 28.1. Middle East Infectious Disease Diagnostics Testing Market Overview
• 28.2. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infectious Disease Diagnostics Testing Market

• 29.1. Africa Infectious Disease Diagnostics Testing Market Overview
• 29.2. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infectious Disease Diagnostics Testing Market Competitive Landscape And Company Profiles

• 30.1. Infectious Disease Diagnostics Testing Market Competitive Landscape
• 30.2. Infectious Disease Diagnostics Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Infectious Disease Diagnostics Testing Market Other Major And Innovative Companies

• 31.1. Becton Dickinson And Company
• 31.2. Quest Diagnostics Incorporated
• 31.3. Grifols S.A.
• 31.4. Hologic Inc.
• 31.5. PerkinElmer Inc.
• 31.6. bioMerieux SA
• 31.7. Quidel Corporation
• 31.8. Sysmex Corporation
• 31.9. Bio-Rad Laboratories Inc.
• 31.10. QIAGEN N.V.
• 31.11. DiaSorin SpA (Luminex)
• 31.12. Myriad Genetics Inc.
• 31.13. Seegene Inc.
• 31.14. Ortho Clinical Diagnostics Inc.
• 31.15. OraSure Technologies Inc.

32. Global Infectious Disease Diagnostics Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease Diagnostics Testing Market

34. Recent Developments In The Infectious Disease Diagnostics Testing Market

35. Infectious Disease Diagnostics Testing Market High Potential Countries, Segments and Strategies

• 35.1 Infectious Disease Diagnostics Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Infectious Disease Diagnostics Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Infectious Disease Diagnostics Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer